Healthcare Sector Insider Trading Activity

Track insider buying and selling in Healthcare stocks. See which executives are buying, net insider activity, and % of float traded across 3,445 companies.
The information provided in this screen is for informational purposes only and does not constitute financial advice. We do not endorse any specific investment based on these criteria.
Companies
Data
Subscribe to access full data
Company Business Sector Market cap ($) # net buying insiders Net value bought ($) % of float bought % of shares held by insiders
Pharmaceuticals & Medical Research Mega (1.3tn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mega (675.0bn) -1–5 -$10M–$100M -0–15% 0–15%
US Abbvie Inc (ABBV)
Pharmaceuticals & Medical Research Mega (521.5bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Mega (368.9bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Mega (363.0bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Mega (305.7bn) 0 No activity — —
CH Novartis AG (NOVN)
Pharmaceuticals & Medical Research Mega (301.4bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Mega (257.4bn) -1–5 -$1M–$10M -0–15% 0–15%
US Amgen Inc (AMGN)
Pharmaceuticals & Medical Research Mega (249.4bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mega (249.4bn) 1–5 $10M–$100M 0–15% 0–15%
Pharmaceuticals & Medical Research Mega (208.5bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Mega (201.4bn) 0 No activity — 0–15%
Healthcare Services Large (199.9bn) -1–5 -$10M–$100M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (174.0bn) 0 No activity — 0–15%
Healthcare Services Large (161.7bn) -1–5 -$10M–$100M -0–15% 0–15%
Healthcare Services Large (152.6bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (137.5bn) 0 No activity — 0–15%
Healthcare Services Large (134.3bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (129.3bn) -1–5 -$100M+ -0–15% 0–15%
Pharmaceuticals & Medical Research Large (128.8bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (107.4bn) 0 No activity — 0–15%
Healthcare Services Large (106.9bn) -1–5 -$10M–$100M -0–15% 15–50%
Healthcare Services Large (104.1bn) 1–5 $1M–$10M 0–15% 0–15%
US Moderna Inc (MRNA)
Pharmaceuticals & Medical Research Large (101.5bn) 0 No activity — 0–15%
GB GSK plc (GSK)
Pharmaceuticals & Medical Research Large (100.3bn) 11–20 $100K–$1M 0–15% 0–15%
FR Sanofi SA (SAN)
Pharmaceuticals & Medical Research Large (97.8bn) 0 No activity — 0–15%
Healthcare Services Large (93.7bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (93.4bn) -1–5 -$10M–$100M -0–15% 0–15%
AU CSL Ltd (CSL)
Pharmaceuticals & Medical Research Large (90.6bn) 0 No activity — 0–15%
Healthcare Services Large (80.4bn) 0 No activity — 0–15%
Healthcare Services Large (79.6bn) 1–5 < $100K 0–15% 15–50%
Pharmaceuticals & Medical Research Large (77.0bn) 0 No activity — —
Healthcare Services Large (64.5bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (64.2bn) 1–5 $100K–$1M 0–15% 0–15%
Pharmaceuticals & Medical Research Large (63.7bn) 0 No activity — 0–15%
DE Bayer AG (BAYN)
Pharmaceuticals & Medical Research Large (62.2bn) 0 No activity — —
Pharmaceuticals & Medical Research Large (62.0bn) 0 No activity — 0–15%
BE Ucb SA (UCB)
Pharmaceuticals & Medical Research Large (61.9bn) 1–5 < $100K 0–15% 15–50%
NL argenx SE (ARGX)
Pharmaceuticals & Medical Research Large (61.1bn) -6–10 -$10M–$100M -0–15% —
Healthcare Services Large (60.8bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (60.7bn) 0 No activity — 0–15%
Healthcare Services Large (59.7bn) 0 No activity — 0–15%
Healthcare Services Large (58.8bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (56.6bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (54.0bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (52.8bn) -1–5 -$10M–$100M -0–15% 0–15%
US Medline Inc (MDLN)
Healthcare Services Large (52.6bn) -1–5 -$100M+ -0–15% 0–15%
Healthcare Services Large (52.2bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (50.0bn) -1–5 -< $100K -0–15% 0–15%
Pharmaceuticals & Medical Research Large (49.8bn) 0 No activity — 50%+
Healthcare Services Large (46.0bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (44.8bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (44.7bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Large (44.3bn) 0 No activity — 0–15%
US Seagen Inc (SGEN)
Pharmaceuticals & Medical Research Large (43.2bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (39.0bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (37.7bn) 1–5 $100K–$1M 0–15% 0–15%
US Biogen Inc (BIIB)
Pharmaceuticals & Medical Research Large (36.8bn) 0 No activity — 0–15%
Healthcare Services Large (36.5bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (36.1bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (33.4bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (33.1bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (32.7bn) -1–5 -$1M–$10M -0–15% 15–50%
DK Genmab A/S (GMAB)
Pharmaceuticals & Medical Research Large (32.5bn) -1–5 -$1M–$10M -0–15% 0–15%
Healthcare Services Large (32.2bn) -1–5 -$100M+ -0–15% 0–15%
Pharmaceuticals & Medical Research Large (32.0bn) 0 No activity — 50%+
US Dexcom Inc (DXCM)
Healthcare Services Large (31.1bn) 0 No activity — 0–15%
CH Alcon AG (ALC)
Healthcare Services Large (30.8bn) 0 No activity — 0–15%
Healthcare Services Large (29.8bn) -1–5 -$100K–$1M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (29.2bn) 1–5 -$100K–$1M -0–15% 50%+
Healthcare Services Large (29.1bn) 1–5 $100K–$1M 0–15% 15–50%
Pharmaceuticals & Medical Research Large (28.9bn) 0 No activity — 0–15%
Healthcare Services Large (28.6bn) 0 No activity — 0–15%
Healthcare Services Large (28.4bn) -1–5 -$1M–$10M -0–15% 0–15%
US Cerner Corp (CERN)
Healthcare Services Large (27.9bn) 0 No activity — 0–15%
Healthcare Services Large (26.8bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Large (26.6bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (25.9bn) -1–5 -$10M–$100M -0–15% 15–50%
Pharmaceuticals & Medical Research Large (25.4bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (25.0bn) -1–5 -$1M–$10M -0–15% 0–15%
US Incyte Corp (INCY)
Pharmaceuticals & Medical Research Large (24.5bn) -1–5 -$10M–$100M -0–15% 0–15%
Healthcare Services Large (24.0bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Large (24.0bn) -1–5 -$1M–$10M -0–15% 0–15%
US Viatris Inc (VTRS)
Pharmaceuticals & Medical Research Large (23.9bn) 0 No activity — 0–15%
Healthcare Services Large (23.9bn) 0 No activity — 0–15%
DE Biontech SE (BNTX)
Pharmaceuticals & Medical Research Large (23.1bn) -1–5 -$10M–$100M -0–15% 50%+
Healthcare Services Large (21.2bn) -6–10 -$10M–$100M -0–15% 0–15%
Healthcare Services Large (21.1bn) 0 No activity — 15–50%
Pharmaceuticals & Medical Research Large (21.0bn) 1–5 $100K–$1M 0–15% 0–15%
Pharmaceuticals & Medical Research Large (20.9bn) -6–10 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (20.3bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (20.0bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (19.4bn) 0 No activity — 50%+
Pharmaceuticals & Medical Research Large (18.8bn) -1–5 -$100M+ -0–15% 15–50%
Healthcare Services Large (18.5bn) -1–5 -$100K–$1M -0–15% 0–15%
Healthcare Services Large (18.4bn) 1–5 $100K–$1M 0–15% 15–50%
Healthcare Services Large (17.7bn) 0 No activity — 50%+
Healthcare Services Large (17.6bn) 0 No activity — 0–15%
Pharmaceuticals & Medical Research Large (17.5bn) -1–5 -$1M–$10M -0–15% 0–15%
Pharmaceuticals & Medical Research Large (17.3bn) 0 No activity — 0–15%
Loading...